search
Back to results

The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 (CircumVent)

Primary Purpose

SARS-CoV-2 Acute Respiratory Disease, COVID-19 Respiratory Infection

Status
Unknown status
Phase
Not Applicable
Locations
Nigeria
Study Type
Interventional
Intervention
CPAP helmet
Standard of care non-helmet based CPAP ventilation
Sponsored by
New York University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for SARS-CoV-2 Acute Respiratory Disease focused on measuring non-invasive ventilation, implementation science

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients admitted to a study site with respiratory distress and suspected or confirmed COVID-19 infection

Exclusion Criteria:

  • Patients who do not meet eligibility criteria

Sites / Locations

  • Nigerian Institute of Medical ResearchRecruiting
  • Federal Medical Center, AbeokutaRecruiting
  • Alex Ekwueme Federal University Teaching HospitalRecruiting
  • Enugu State University Teaching HospitalRecruiting
  • University College HospitalRecruiting
  • Aminu Kano Teaching HospitalRecruiting
  • Federal Medical Center, Ebute MettaRecruiting
  • Lagos University Teaching HospitalRecruiting
  • Delta State University Teaching HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CPAP- Helmet Users

Non-CPAP helmet users

Arm Description

Patients admitted to a study site with suspected or confirmed COVID-19 and who consented to using the CPAP helmet

Patients admitted to a study site with suspected or confirmed COVID-19 but who did not use a CPAP helmet

Outcomes

Primary Outcome Measures

Respiratory rate
mild, 11-19/min; moderate, 20-24/min; severe, 25-30/min; very severe, >30 or <=10/min
Pulse Oximetry
mild >90; moderate <=90; severe, <88
Disposition
Died; Improved; Intubated

Secondary Outcome Measures

Feasibility of using CPAP/O2 helmet solution
Feasibility of Intervention Measure (FIM, Weiner et al. 2017), 4-item instrument with a 5-point ordinal scale (1 = minimum, 5 = maximum) that takes < 5 minutes to complete. Higher scores imply better outcome (greater feasibility).
Adaptability of the strategy for implementing CPAP/O2 helmet solution
Qualitative description of helmet use adaptations via self-report; Observed adaptation to patient characteristics
Acceptability of CPAP/O2 helmet solution for non-invasive management of COVID-19
Acceptability of Intervention Measure (AIM, Weiner et al. 2017), a 4-item instrument with a 5-point ordinal scale (1= minimum, 5 = maximum). Higher scores imply better outcome (greater acceptability).

Full Information

First Posted
June 8, 2021
Last Updated
June 17, 2021
Sponsor
New York University
Collaborators
Aliko Dangote Foundation, Nigerian Institute of Medical Research, CDC Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT04929691
Brief Title
The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19
Acronym
CircumVent
Official Title
The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Using an Implementation Research Framework
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 13, 2020 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
New York University
Collaborators
Aliko Dangote Foundation, Nigerian Institute of Medical Research, CDC Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the CircumVent Project is to evaluate the feasibility, adaptability and acceptability of a CPAP/O2 helmet solution for non-invasive ventilation among patients with COVID-19 and health workers in eight COVID-19 treatment and isolation centers in Nigeria.
Detailed Description
Acute respiratory failure, a major cause of death in COVID-19, is managed with high-flow oxygen therapy via invasive mechanical ventilation. In resource-limited settings like Nigeria the shortage of ventilators and oxygen supply make this option challenging. Evidence-based non-invasive alternatives to mechanical ventilation such as the use of continuous positive airway pressure (CPAP) devices exist, but there have been concerns that non-invasive ventilation may expose healthcare workers to infection from aerosolized dispersion of SARS-CoV-2. The investigators propose to evaluate the feasibility, adaptability and acceptability of a CPAP/O2 helmet solution for non-invasive ventilation among patients with COVID-19 and health workers in eight COVID-19 treatment and isolation centers in Nigeria. The study will occur in 4 stages: 1) Convene a Steering Committee of key stakeholders and recruit implementation sites; 2) Use the integrated Promoting Action on Research Implementation in Health Services (i-PARiHS) framework to guide a needs assessment of treatment centers' capacity to use high-flow oxygen therapy to treat COVID-19 patients, and utilize the findings to develop an implementation strategy for use of CPAP/ O2 helmet solution; 3) Build infrastructure to support training and data monitoring processes and to develop implementation protocols to evaluate the adaptability of the strategy for the use of the CPAP/O2 helmet; and 4) Train health workers, distribute a CPAP/O2 helmet solution for non-invasive ventilation, pilot test the implementation strategy, and assess feasibility of its use and acceptability that includes monitoring altered risk of SARS-CoV-2 infection among healthcare workers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SARS-CoV-2 Acute Respiratory Disease, COVID-19 Respiratory Infection
Keywords
non-invasive ventilation, implementation science

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study will occur in 4 stages: 1) Convene a Steering Committee of key stakeholders and recruit implementation sites; 2) Use the integrated Promoting Action on Research Implementation in Health Services (i-PARiHS) framework to guide a needs assessment of treatment centers' capacity to use high-flow oxygen therapy to treat COVID-19 patients, and utilize the findings to develop an implementation strategy for use of CPAP/ O2 helmet solution; 3) Build infrastructure to support training and data monitoring processes and to develop implementation protocols to evaluate the adaptability of the strategy for the use of the CPAP/O2 helmet; and 4) Train health workers, distribute a CPAP/O2 helmet solution for non-invasive ventilation, pilot test the implementation strategy, and assess feasibility of its use and acceptability that includes monitoring altered risk of SARS-CoV-2 infection among healthcare workers.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
370 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CPAP- Helmet Users
Arm Type
Experimental
Arm Description
Patients admitted to a study site with suspected or confirmed COVID-19 and who consented to using the CPAP helmet
Arm Title
Non-CPAP helmet users
Arm Type
Active Comparator
Arm Description
Patients admitted to a study site with suspected or confirmed COVID-19 but who did not use a CPAP helmet
Intervention Type
Device
Intervention Name(s)
CPAP helmet
Intervention Description
helmet-based CPAP ventilation for eligible patients; assess the feasibility and acceptability of the helmet-based CPAP ventilation
Intervention Type
Other
Intervention Name(s)
Standard of care non-helmet based CPAP ventilation
Intervention Description
Standard of care ventilation without helmet-based CPAP
Primary Outcome Measure Information:
Title
Respiratory rate
Description
mild, 11-19/min; moderate, 20-24/min; severe, 25-30/min; very severe, >30 or <=10/min
Time Frame
1-4 weeks while on admission
Title
Pulse Oximetry
Description
mild >90; moderate <=90; severe, <88
Time Frame
1-4 weeks while on admission
Title
Disposition
Description
Died; Improved; Intubated
Time Frame
1-4 weeks while on admission
Secondary Outcome Measure Information:
Title
Feasibility of using CPAP/O2 helmet solution
Description
Feasibility of Intervention Measure (FIM, Weiner et al. 2017), 4-item instrument with a 5-point ordinal scale (1 = minimum, 5 = maximum) that takes < 5 minutes to complete. Higher scores imply better outcome (greater feasibility).
Time Frame
1- 4 weeks while on admission
Title
Adaptability of the strategy for implementing CPAP/O2 helmet solution
Description
Qualitative description of helmet use adaptations via self-report; Observed adaptation to patient characteristics
Time Frame
1-4 weeks while on admission
Title
Acceptability of CPAP/O2 helmet solution for non-invasive management of COVID-19
Description
Acceptability of Intervention Measure (AIM, Weiner et al. 2017), a 4-item instrument with a 5-point ordinal scale (1= minimum, 5 = maximum). Higher scores imply better outcome (greater acceptability).
Time Frame
1-4 weeks while on admission

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients admitted to a study site with respiratory distress and suspected or confirmed COVID-19 infection Exclusion Criteria: Patients who do not meet eligibility criteria
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Andre Fenton, PhD
Phone
+1-212-992-6573
Email
afenton@nyu.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Olugbenga Ogedegbe, MD, MPH
Phone
+1-646-501-3435
Email
Olugbenga.Ogedegbe@nyulangone.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Babatunde L Salako, MBBS, FRCP
Organizational Affiliation
Nigerian Institute for Medical Research, Lagos, Nigeria
Official's Role
Study Director
Facility Information:
Facility Name
Nigerian Institute of Medical Research
City
Yaba
State/Province
Lagos
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oliver Ezechi, MBBS, FWACS
Phone
+2348033065683
Email
oezechi@nimr.gov.ng
First Name & Middle Initial & Last Name & Degree
Babatunde L Salako, MBBS, FRCP
Facility Name
Federal Medical Center, Abeokuta
City
Abeokuta
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adenike Odewabi, MBBS
Facility Name
Alex Ekwueme Federal University Teaching Hospital
City
Enugu
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ifeoma Ulasi, MBBS
Facility Name
Enugu State University Teaching Hospital
City
Enugu
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ifeoma Ulasi, MBBS
Facility Name
University College Hospital
City
Ibadan
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Samuel O Ajayi, MBBS
Facility Name
Aminu Kano Teaching Hospital
City
Kano
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aliyu Abdu, MBBS, FMCP
First Name & Middle Initial & Last Name & Degree
Baba M Musa, MBBS, FRCP
Facility Name
Federal Medical Center, Ebute Metta
City
Lagos
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adedamola Dada, MBBS
Facility Name
Lagos University Teaching Hospital
City
Lagos
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Muyiwa Rotimi, MBBS
Facility Name
Delta State University Teaching Hospital
City
Oghara
Country
Nigeria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Onome Ogueh, MBBS

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Any study data to be shared will need to conform to Nigeria national data regulations.
Citations:
PubMed Identifier
29595563
Citation
Patel BK, Wolfe KS, MacKenzie EL, Salem D, Esbrook CL, Pawlik AJ, Stulberg M, Kemple C, Teele M, Zeleny E, Macleod J, Pohlman AS, Hall JB, Kress JP. One-Year Outcomes in Patients With Acute Respiratory Distress Syndrome Enrolled in a Randomized Clinical Trial of Helmet Versus Facemask Noninvasive Ventilation. Crit Care Med. 2018 Jul;46(7):1078-1084. doi: 10.1097/CCM.0000000000003124.
Results Reference
background
PubMed Identifier
27549178
Citation
Liu Q, Gao Y, Chen R, Cheng Z. Noninvasive ventilation with helmet versus control strategy in patients with acute respiratory failure: a systematic review and meta-analysis of controlled studies. Crit Care. 2016 Aug 23;20(1):265. doi: 10.1186/s13054-016-1449-4.
Results Reference
background
PubMed Identifier
27179463
Citation
Beitler JR, Owens RL, Malhotra A. Unmasking a Role for Noninvasive Ventilation in Early Acute Respiratory Distress Syndrome. JAMA. 2016 Jun 14;315(22):2401-3. doi: 10.1001/jama.2016.5987. No abstract available.
Results Reference
background
PubMed Identifier
24817030
Citation
Brambilla AM, Aliberti S, Prina E, Nicoli F, Del Forno M, Nava S, Ferrari G, Corradi F, Pelosi P, Bignamini A, Tarsia P, Cosentini R. Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med. 2014 Jul;40(7):942-9. doi: 10.1007/s00134-014-3325-5. Epub 2014 May 10. Erratum In: Intensive Care Med. 2014 Aug;40(8):1187.
Results Reference
background
PubMed Identifier
28899408
Citation
Chiumello D, Brochard L, Marini JJ, Slutsky AS, Mancebo J, Ranieri VM, Thompson BT, Papazian L, Schultz MJ, Amato M, Gattinoni L, Mercat A, Pesenti A, Talmor D, Vincent JL. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care. 2017 Sep 12;21(1):240. doi: 10.1186/s13054-017-1820-0.
Results Reference
background
PubMed Identifier
11066186
Citation
Delclaux C, L'Her E, Alberti C, Mancebo J, Abroug F, Conti G, Guerin C, Schortgen F, Lefort Y, Antonelli M, Lepage E, Lemaire F, Brochard L. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. JAMA. 2000 Nov 8;284(18):2352-60. doi: 10.1001/jama.284.18.2352.
Results Reference
background
PubMed Identifier
34446110
Citation
Ahonkhai AA, Musa AZ, Fenton AA, Aliyu MH, Ofotokun I, Hornstein A, Musa BM, Nwosu N, Ulasi I, Ajayi S, Falade C, Dada A, Abdu A, Sunday M, Odewabi A, Rotimi MK, Ogueh O, Steinbach A, Ogedegbe G, Salako BL, Ezechi OC. The CircumVent Project: a CPAP/O2 helmet solution for non-invasive ventilation using an implementation research framework. Implement Sci Commun. 2021 Aug 26;2(1):93. doi: 10.1186/s43058-021-00193-y.
Results Reference
derived
Links:
URL
https://www.circumventproject.com/
Description
Circumvent Project homepage

Learn more about this trial

The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19

We'll reach out to this number within 24 hrs